BioArctic

BioArctic is a brand-new company record, and its full research profile isn't ready yet.

Library

bioarctic.comCrawled Oct 27, 2026

6 pages

BioArctic AB intends to list on Nasdaq Stockholm/en/bioarctic-ab-intends-to-list-on-nasdaq-stockholm-ipo
BioArctic enters into Collaboration with AbbVie for Parkinson’s Disease Research/en/bioarctic-enters-into-collaboration-with-abbvie-for-parkinsons-disease-research
BioArctic and AbbVie collaborated to develop and commercialize BioArctic’s antibodies targeting alpha-synuclein for Parkinson’s disease and other potential uses.
BioArctic Neuroscience and Elos Medtech start collaboration on new treatment for spinal cord injuries/en/bioarctic-neuroscience-and-elos-medtech-start-collaboration-on-new-treatment-for-spinal-cord-injuries
The Swedish biotech company BioArctic Neuroscience and the medtech company Elos Medtech have today signed a cooperation agreement for a new treatment of spinal cord injuries.
BioArctic Neuroscience and Swenora Biotech Enter into exclusive licensing agreement/en/bioarctic-neuroscience-and-swenora-biotech-enter-into-exclusive-licensing-agreement
BioArctic Neuroscience and Swenora Biotech entered an exclusive licensing agreement, granting BioArctic global rights to develop and market a spinal cord injury treatment.

2 pages

Nomination Committee 2018/en/nomination-committee-2018
BioArctic AB’s 2017 Annual General Meeting resolved that the 2018 Nomination Committee members would be selected from the three largest shareholders, as recorded by Euroclear on September 30, 2017.
Nomination Committee 2019/en/nomination-committee-2019
BioArctic AB’s 2018 Annual General Meeting resolved that the 2019 Nomination Committee members would be selected from the three largest shareholders, as recorded by Euroclear on September 30, 2018.

1 page